Feb 10 (Reuters) - U.S. stock index futures dipped on Monday, indicating the S&P 500 would retreat after its best two-day performance in four months, ahead of new Federal Reserve Chair Janet Yellen’s first testimony before lawmakers on Tuesday. Dow Jones industrial average futures were down 0.04 percent at 15,733, S&P 500 futures were down 0.17 percent at 1,790.5 and Nasdaq 100 futures were up 0.04 percent at 3,559.25.
** MCDONALD’S CORP, Friday close $95.92, +0.08 pct premarket
The world’s biggest restaurant chain by revenue on Monday reported better-than-expected global sales at established restaurants for January as gains in Europe and China helped the company offset a sharp decline in the United States.
Same-restaurnat sales, a closely watched gauge of performance, fell 3.3 percent in the United States, a deeper decline than the 1.6 percent drop that analysts expected. The company blamed the severe winter that hit large parts of the country.
** AUTONAVI HOLDINGS LTD, Friday close $16.54, +25.39 pct premarket
The Chinese digital mapping and navigation firm said it had received an offer to be taken private by major shareholder Alibaba Group Holding Ltd.
** BOARDWALK PIPELINE PARTNERS LP, Friday close $24.09, -33.17 pct premarket
The natural gas pipeline company said it reduced its quarterly cash distribution to increase the cash generated internally and reduce leverage. Broadwalk reported a 78 percent fall in its profit, hurt by lower transportation revenue due to expiration of contracts and lower natural gas prices. The company also forecast a lower distributable cash flow for 2014.
** YAHOO INC, Friday close $37.23, +2.42 pct premarket
** YELP INC, Friday close $89.41, +9.44 pct premarket
Yahoo is partnering with consumer reviews website Yelp to beef up local results in its search engine, the Wall Street Journal reported on Saturday.
** DICK’S SPORTING GOODS INC, Friday close $51.1, +6.34 pct premarket
The company, which sells everything from camping and golfing gear to winter wear and guns, estimated fourth-quarter profit above the analysts’ average forecast, helped by a strong jump in same-store sales.
** SAREPTA THERAPEUTICS INC, Friday close $25.86, +4.02 pct premarket
The drug developer said its treatment for Marburg virus infection was well tolerated through the highest dose tested in an early-stage trial.
Marburg hemorrhagic fever, classified as a bioterrorism agent by the Centers for Disease Control and Prevention, is a potentially fatal disease in humans first recognized in 1967.
** KITE REALTY GROUP TRUST, Friday close $6.15, +1.79 pct premarket
The operator of community shopping centers said it would buy Inland Diversified Real Estate Trust Inc for about $1.2 billion in stock. The deal will allow Kite Realty to enter several markets, including Westchester, New York, Bayonne, New Jersey, Las Vegas, Virginia Beach and Salt Lake City, Utah.
** YAMANA GOLD INC, Friday close $9.17, +0.33 pct premarket
The Toronto-based miner reported that full-year production fell short of its forecasts on Monday, blaming the shortfall on problems at new operations that it said had been resolved by the end of 2013.
** BEBE STORES INC, Friday close $5.42, +9.23 pct premarket
The contemporary women’s retailer is exploring a potential sale and is reaching out to private equity firms, people familiar with the matter said on Friday.
** LOEWS CORP, Friday close $45.18, +2.90 pct premarket
** CNA FINANCIAL CORP, Friday close $39.67, +3.10 pct premarket
The company, controlled by the billionaire Tisch family, reported a bigger fourth-quarter loss, hurt by impairment charges.
Lowes’ subsidiary, CNA Financial Corp, said it would sell its life and group insurance business.
** ROCKET FUEL INC, Friday close $50.97, +5.69 pct premarket
Goldman Sachs initiated coverage on the digital advertising technology company's stock with a "buy" rating and price target of $69, according to StreetInsider.com (link.reuters.com/gyf76v)
** INTERCEPT PHARMACEUTICALS INC, Friday close$351.56, +1.26 pct premarket
Wedbush analyst Liana Moussatos reiterated her rating of “outperform” on the drug developer’s stock, citing the mid-stage trial testing of its lead drug, Obeticholic Acid (OCA), in alcoholic hepatitis (AH) patients.
“We project gross annual peak sales of OCA treating AH could reach over $3 billion worldwide”, Moussatos said in a note, raising her price target on the stock to $493 from $449.
** BRISTOL-MYERS SQUIBB CO, Friday close $50.33, +1.13 pct premarket
BMO Capital Markets raised its rating on the drugmaker’s stock to “outperform” from “market perform,” citing a more positive outlook for the company’s immuno-oncology pipeline.
** LEGG MASON INC, Friday close $41.85, +1.00 pct premarket
Analysts at Keefe, Bruyette & Woods raised the rating of the global asset management company’s stock to “outperform” from “market perform”.
“We felt better that the underlying trajectory remains positive and that the stock offers a better risk/reward than we had previously believed,” the analysts said.
** JAMES RIVER COAL, Friday close $0.7402, +21.59 pct premarket
The coal miner said on Friday that it was considering a sale of itself or some parts, or an equity or debt investment, along with other strategic alternatives for the company. (Compiled by Garima Goel in Bangalore; Editing by Simon Jennings)